These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 15774439

  • 1. Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis.
    Deloire MS, Salort E, Bonnet M, Arimone Y, Boudineau M, Amieva H, Barroso B, Ouallet JC, Pachai C, Galliaud E, Petry KG, Dousset V, Fabrigoule C, Brochet B.
    J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):519-26. PubMed ID: 15774439
    [Abstract] [Full Text] [Related]

  • 2. Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging.
    Rovaris M, Iannucci G, Falautano M, Possa F, Martinelli V, Comi G, Filippi M.
    J Neurol Sci; 2002 Mar 30; 195(2):103-9. PubMed ID: 11897239
    [Abstract] [Full Text] [Related]

  • 3. Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis.
    Davies GR, Ramió-Torrentà L, Hadjiprocopis A, Chard DT, Griffin CM, Rashid W, Barker GJ, Kapoor R, Thompson AJ, Miller DH.
    J Neurol Neurosurg Psychiatry; 2004 Jul 30; 75(7):998-1002. PubMed ID: 15201359
    [Abstract] [Full Text] [Related]

  • 4. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
    Sacco R, Bisecco A, Corbo D, Della Corte M, d'Ambrosio A, Docimo R, Gallo A, Esposito F, Esposito S, Cirillo M, Lavorgna L, Tedeschi G, Bonavita S.
    J Neurol; 2015 Jul 30; 262(7):1691-7. PubMed ID: 25957638
    [Abstract] [Full Text] [Related]

  • 5. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC, Gold SM, Lee B, Montag M, Horsfall J, O'Connor MF, Sicotte NL.
    Neuroimage Clin; 2015 Jul 30; 8():440-7. PubMed ID: 26106524
    [Abstract] [Full Text] [Related]

  • 6. Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities.
    Traboulsee A, Dehmeshki J, Peters KR, Griffin CM, Brex PA, Silver N, Ciccarrelli O, Chard DT, Barker GJ, Thompson AJ, Miller DH.
    Mult Scler; 2003 Dec 30; 9(6):566-73. PubMed ID: 14664468
    [Abstract] [Full Text] [Related]

  • 7. Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis.
    Davies GR, Altmann DR, Hadjiprocopis A, Rashid W, Chard DT, Griffin CM, Tofts PS, Barker GJ, Kapoor R, Thompson AJ, Miller DH.
    J Neurol; 2005 Sep 30; 252(9):1037-44. PubMed ID: 15834645
    [Abstract] [Full Text] [Related]

  • 8. Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis.
    Tur C, Penny S, Khaleeli Z, Altmann DR, Cipolotti L, Ron M, Thompson AJ, Ciccarelli O.
    Mult Scler; 2011 Nov 30; 17(11):1324-32. PubMed ID: 21803874
    [Abstract] [Full Text] [Related]

  • 9. Normal appearing white matter permeability: a marker of inflammation and information processing speed deficit among relapsing remitting multiple sclerosis patients.
    Eftekhari E, Hojjat SP, Vitorino R, Carroll TJ, Cantrell CG, Lee L, Taylor MW, Morrow SA, Benhabib H, Aviv RI, Kassner A.
    Neuroradiology; 2017 Aug 30; 59(8):771-780. PubMed ID: 28623483
    [Abstract] [Full Text] [Related]

  • 10. The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis.
    Griffin CM, Chard DT, Parker GJ, Barker GJ, Thompson AJ, Miller DH.
    J Neurol; 2002 Feb 30; 249(2):193-9. PubMed ID: 11985386
    [Abstract] [Full Text] [Related]

  • 11. Brain atrophy as a marker of cognitive impairment in mildly disabling relapsing-remitting multiple sclerosis.
    Sánchez MP, Nieto A, Barroso J, Martín V, Hernández MA.
    Eur J Neurol; 2008 Oct 30; 15(10):1091-9. PubMed ID: 18727673
    [Abstract] [Full Text] [Related]

  • 12. Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
    Al-Radaideh A, Mougin OE, Lim SY, Chou IJ, Constantinescu CS, Gowland P.
    NMR Biomed; 2015 Nov 30; 28(11):1374-82. PubMed ID: 26346925
    [Abstract] [Full Text] [Related]

  • 13. MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R, De Masi R, Nasuelli D, Bragadin LM, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M.
    Neuroradiology; 2001 Apr 30; 43(4):272-8. PubMed ID: 11338408
    [Abstract] [Full Text] [Related]

  • 14. Thalamic atrophy predicts cognitive impairment in relapsing remitting multiple sclerosis. Effect on instrumental activities of daily living and employment status.
    Papathanasiou A, Messinis L, Zampakis P, Panagiotakis G, Gourzis P, Georgiou V, Papathanasopoulos P.
    J Neurol Sci; 2015 Nov 15; 358(1-2):236-42. PubMed ID: 26359854
    [Abstract] [Full Text] [Related]

  • 15. Histogram analysis of diffusion measures in clinically isolated syndromes and relapsing-remitting multiple sclerosis.
    Yu CS, Lin FC, Liu Y, Duan Y, Lei H, Li KC.
    Eur J Radiol; 2008 Nov 15; 68(2):328-34. PubMed ID: 17928182
    [Abstract] [Full Text] [Related]

  • 16. Associations between cognitive and clinical disability across MS subtypes: The role of the underlying brain damage.
    Gois LCP, Pimentel-Silva LR, Damasceno BP, Damasceno A.
    Mult Scler Relat Disord; 2021 Feb 15; 48():102701. PubMed ID: 33477004
    [Abstract] [Full Text] [Related]

  • 17. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A, Müller-Lenke N, Naegelin Y, Kalt G, Bendfeldt K, Kuster P, Stoecklin M, Gass A, Sprenger T, Radue EW, Kappos L, Penner IK.
    Mult Scler; 2013 Sep 15; 19(10):1290-6. PubMed ID: 23459568
    [Abstract] [Full Text] [Related]

  • 18. Longitudinal microstructural MRI markers of demyelination and neurodegeneration in early relapsing-remitting multiple sclerosis: Magnetisation transfer, water diffusion and g-ratio.
    York EN, Meijboom R, Thrippleton MJ, Bastin ME, Kampaite A, White N, Chandran S, Waldman AD, FutureMS Consortium.
    Neuroimage Clin; 2022 Sep 15; 36():103228. PubMed ID: 36265199
    [Abstract] [Full Text] [Related]

  • 19. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease.
    Vrenken H, Pouwels PJ, Ropele S, Knol DL, Geurts JJ, Polman CH, Barkhof F, Castelijns JA.
    Mult Scler; 2007 Jul 15; 13(6):708-16. PubMed ID: 17613597
    [Abstract] [Full Text] [Related]

  • 20. Investigation of quantitative magnetisation transfer parameters of lesions and normal appearing white matter in multiple sclerosis.
    Cercignani M, Basile B, Spanò B, Comanducci G, Fasano F, Caltagirone C, Nocentini U, Bozzali M.
    NMR Biomed; 2009 Jul 15; 22(6):646-53. PubMed ID: 19322806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.